Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells - Test2 - elhamkhani - TriplyDB

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

http://www.wikidata.org/entity/Q24563090

about

Regulation of pulmonary fibrosis by chemokine receptor CXCR3 Gliptins and their target dipeptidyl peptidase 4: implications for the treatment of vascular disease Acute Atherosis of the Uterine Spiral Arteries: Clinicopathologic Implications Adiponectin as a potential biomarker of vascular disease The role of T and B cells in human atherosclerosis and atherothrombosis Regulation of atherogenesis by chemokines and chemokine receptors The multifaceted functions of CXCL10 in cardiovascular disease IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammation Endothelial Response to Glucocorticoids in Inflammatory Diseases The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart Structure-function relationship between the human chemokine receptor CXCR3 and its ligands Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria Immunological profile of silent brain infarction and lacunar stroke PRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ Costimulation Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands The Biology of Autoimmune Response in the Scurfy Mice that Lack the CD4+Foxp3+ Regulatory T-Cells A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation.Molecular imaging in atherosclerosis.Neutrophils, lymphocytes, and monocytes exhibit diverse behaviors in transendothelial and subendothelial migrations under coculture with smooth muscle cells in disturbed flow Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.Specificity tuning of antibody fragments to neutralize two human chemokines with a single agent Innate and adaptive immunity in atherosclerosis.Characterization of heat shock protein-specific T cells in atherosclerosis.CXCR3 controls T-cell accumulation in fat inflammation Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3 Tumor necrosis factor (TNF)-α induction of CXCL10 in endothelial cells requires protein arginine methyltransferase 5 (PRMT5)-mediated nuclear factor (NF)-κB p65 methylation.Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.The role of interferon-γ inducible protein-10 in a mouse model of acute liver injury post induced pluripotent stem cells transplantation Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.CXCR3 in T cell function.Rapid leukocyte integrin activation by chemokines.High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.Expression of chemokine receptors in vernal keratoconjunctivitis.Immunization associated with erectile dysfunction based on cross-sectional and genetic analyses.

P2860

Q24563456-76CE029B-56B2-4D62-9241-84E98D8F6C88 Q26741067-E8BD553A-15B4-4009-9E94-1E585288A86D Q26777023-DA4F8C70-D12C-4336-9350-8923A1B374C6 Q26821925-F2D5D6C3-34DE-4463-832D-3E82979C13C1 Q27000791-EB0C5E61-E2CC-453B-A6DA-EC08A2978103 Q27003124-5672E16C-6529-4DB6-B088-26BAF482D9E9 Q27010051-B8AE0588-7424-45F7-AF3F-8A36DBD587F3 Q27022474-A7B2F548-8DA6-456D-9D77-6512F6D77BA3 Q28073947-EEDF8F2A-725E-4976-BF2D-61C849443F56 Q28079006-0D6B5546-9D6C-4DD7-977C-DFC180A0D5A8 Q28213616-DADF25C4-D0BB-4C67-A298-4589DA0DB232 Q28359694-28B72296-5103-49FD-B7CF-6A020C347847 Q28486022-FF5F46A5-9C73-4516-872A-F3E37A4E78C5 Q28534571-6F64BB91-470E-466F-BB80-62DB3A9A3249 Q28550383-1EB1AD9E-1ACD-4AE2-940F-8FACE0773E5D Q28583515-B79987F9-64EE-478D-9701-0EE94F490E47 Q30413157-4EB62F4C-B109-4383-8988-9B4E3F87A0B5 Q30419044-35FE5AD9-3BB9-467C-8BC4-45CEB1F1461F Q30478541-35631A52-46EE-4AD6-B4BA-9A3522C714EC Q30479642-22F86D00-595D-4F89-9E37-2D9EE58EDD5D Q33288811-AC234316-4621-4DF4-9C59-52FF646E48AC Q33306319-530A2C0D-DA28-4037-9E27-523B51AAC157 Q33523566-4FBAE8BF-16BE-4BD9-AE2D-B850E348C703 Q33659705-F469C1DD-EAC0-44D1-93F4-A0A5BC8C5036 Q33859286-6AC5EF6E-D2F0-496F-809C-C8842983DBFE Q33915626-941D9338-E0F2-4005-9F0C-973BE632ADFE Q34007358-6C4518EE-ECF5-467D-A036-18A407384C76 Q34075896-5FAC5045-5793-4F97-A742-04310FD2BCBA Q34089207-6490829E-36F1-4888-B569-67BAA21FDBCB Q34334697-4CADF6CC-D4E4-4BD7-9B6F-644F5F5141C6 Q34430115-B67CD03F-DCA3-4525-A934-267978F11ED8 Q34507030-09BB2F02-13C8-40AD-8ACF-A699E2883BB3 Q34509942-4A46D683-E8CC-4992-AFD7-CFB2FA99658A Q34726782-AC7CA24C-F5E2-4254-8C58-CA8F0B13E10C Q34862111-AEDC3A3A-FBA8-45F0-A339-E1DF9410852F Q35072075-468C2E72-502D-44E3-B1A1-449FF27912B7 Q35143874-5C817A4A-C47D-4229-B452-3EDD23DD4B50 Q35223948-0537AB52-783E-4EF9-BD80-60696997B919 Q35317841-C695674E-16EB-49A7-849E-B0904FF18C7A Q35365403-7A9D979E-42ED-4254-8781-3B05F3BE8DF4

P2860

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

http://www.wikidata.org/entity/Q24563090

description

1999 nî lūn-bûn

@nan

1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Differential expression of thr ...... uman atheroma-associated cells

@ast

Differential expression of thr ...... uman atheroma-associated cells

@en

Differential expression of thr ...... uman atheroma-associated cells

@nl

type

label

Differential expression of thr ...... uman atheroma-associated cells

@ast

Differential expression of thr ...... uman atheroma-associated cells

@en

Differential expression of thr ...... uman atheroma-associated cells

@nl

prefLabel

Differential expression of thr ...... uman atheroma-associated cells

@ast

Differential expression of thr ...... uman atheroma-associated cells

@en

Differential expression of thr ...... uman atheroma-associated cells

@nl

P1433

Q24563090-E55C1C12-BD65-4206-A341-6AE371D620E8

P1476

Q24563090-CA44F730-F112-433B-92B4-ED07BBFF726F

P2093

Q24563090-00920E52-D42D-40ED-A627-F0D4A4F601B1

Q24563090-1EE491D3-8217-4086-9A96-2D81E7075C69

Q24563090-41A460F7-E681-4799-A9ED-57E3416C3B24

Q24563090-78D637B0-5FDE-4DA2-8749-BBE70D37EBBD

Q24563090-8213E949-EC94-4FB3-A218-EF4EE5506D67

Q24563090-9E14232C-A5C8-4056-820A-E6F735D6B3B4

Q24563090-C1DF49BE-E50E-4472-9702-E3260B21F057

P2860

Q24563090-058025C9-551E-450E-BB55-0648B199F750

Q24563090-0CA01EE0-1F9D-47F3-BD53-161272DEAD75

Q24563090-19DA37EF-2848-4BAC-BC98-3119229D6B14

Q24563090-206B451F-10B3-4D94-B554-791F232201BA

Q24563090-24A82331-D3D9-4D55-94C9-74D942976774

Q24563090-2F1BE715-1ECC-46B8-BC6D-33DA2B1C55E4

Q24563090-32E709A8-A0FE-4106-9A28-B6C1AE60E5B9

Q24563090-39D26455-07BB-405D-A411-2E26A4F54B1E

Q24563090-40A9AD81-6A12-4809-996F-C5ABE3319E6D

Q24563090-42D88673-3CBE-4500-A828-396FB119D835

P304

Q24563090-3F8F0F44-2765-4942-9CB7-5818C4B4300A

P31

Q24563090-2EB3DFCA-8CA4-4BDD-A0D9-340B6E200B4B

P3181

Q24563090-8CADD5CD-F137-4022-8AAD-5979B9C02625

P356

Q24563090-941CE837-1AEB-4372-9375-04A24B185D24

P407

Q24563090-59E38B0E-099A-4ABE-A5BE-89FBE9070BAA

P433

Q24563090-5120AF69-AB13-4210-9028-E42EF54E4906

P478

Q24563090-1777F585-8970-4219-8031-7ACDA7A4A88D

P577

Q24563090-032B5B98-6914-4E55-991F-85625FD680A4

P698

Q24563090-6C7F7541-CB47-45DD-A455-B001353E88ED

P921

Q24563090-3A3C0A38-AC13-48DD-B4F6-1360E0652BEC

P932

Q24563090-D87A6A8F-B6D0-485B-9112-1D8565FC74AC

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Differential expression of thr ...... uman atheroma-associated cells

@en

P2093

A D Luster

http://www.w3.org/2001/XMLSchema#string

A S Iarossi

http://www.w3.org/2001/XMLSchema#string

A Sauty

http://www.w3.org/2001/XMLSchema#string

F Mach

http://www.w3.org/2001/XMLSchema#string

G K Sukhova

http://www.w3.org/2001/XMLSchema#string

K Neote

http://www.w3.org/2001/XMLSchema#string

P Libby

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

Human Mig chemokine: biochemical and functional characterization

Atherosclerosis — An Inflammatory Disease

Mig and IP-10: CXC chemokines that target lymphocytes

Chemokines--chemotactic cytokines that mediate inflammation

P304

1041-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3165228

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI6993

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

1999-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10525042

http://www.w3.org/2001/XMLSchema#string

P921

P932

408576

http://www.w3.org/2001/XMLSchema#string